Published in Cancer Weekly, February 11th, 2003
"There is mounting evidence that hematological malignancies are increased in systemic lupus erythematosus, and the risk of certain solid tumors may also be increased," said Sasha Bernatsky and colleagues at Montreal General Hospital and McGill University in Montreal, Canada.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.